Shushant Jain

Shushant Jain

UNVERIFIED PROFILE

Are you Shushant Jain?   Register this Author

Register author
Shushant Jain

Shushant Jain

Publications by authors named "Shushant Jain"

Are you Shushant Jain?   Register this Author

20Publications

561Reads

16Profile Views

High content screening in neurodegenerative diseases.

J Vis Exp 2012 Jan 6(59):e3452. Epub 2012 Jan 6.

Department of Clinical Genetics, VU University Medical Center.

View Article

Download full-text PDF

Source
http://www.jove.com/details.php?id=3452
Publisher Site
http://dx.doi.org/10.3791/3452DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369774PMC
January 2012

The complete automation of cell culture: improvements for high-throughput and high-content screening.

J Biomol Screen 2011 Sep 20;16(8):932-9. Epub 2011 Jul 20.

VUMC-Clinical Genetics, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1087057111413920DOI Listing
September 2011

From single genes to gene networks: high-throughput-high-content screening for neurological disease.

Neuron 2010 Oct;68(2):207-17

Department of Clinical Genetics, VU University Medical Center Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuron.2010.10.010DOI Listing
October 2010

Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.

Neurodegener Dis 2007 6;4(5):386-91. Epub 2007 Jul 6.

Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Research Center, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000105160DOI Listing
October 2007

The R1441C mutation of LRRK2 disrupts GTP hydrolysis.

Biochem Biophys Res Commun 2007 Jun 10;357(3):668-71. Epub 2007 Apr 10.

Laboratory of Neurogenetics, National Institute on Aging, 35 Convent Drive, Bethesda, MD 20892-3707, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X0700689
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2007.04.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939973PMC
June 2007

Molecular genetic pathways in Parkinson's disease: a review.

Clin Sci (Lond) 2005 Oct;109(4):355-64

Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CS20050106DOI Listing
October 2005

Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.

Ann Neurol 2005 Mar;57(3):453-6

Molecular Genetics Unit, National Institute on Aging, National Institutes of Health, Department of Health and Human Services, Porter Neuroscience Research Center, 9000 Rockville Pike, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.20401DOI Listing
March 2005

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.

Lancet 2005 Jan 29-Feb 4;365(9457):410-2

Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(05)17828-3DOI Listing
February 2005

A common LRRK2 mutation in idiopathic Parkinson's disease.

Lancet 2005 Jan 29-Feb 4;365(9457):415-6

Department of Molecular Neuroscience, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(05)17830-1DOI Listing
February 2005